academic publishing
Throughout the time I’ve been a commissioning editor for science-related articles for news outlets, I’ve always sought and published articles about academic publishing. It’s the part of the scientific enterprise that seems to have been shaped the least by science’s democratic and introspective impulses. It’s
IMRaD structure
This prompt arose in response to Stuart Ritchie’s response to a suggestion in an editorial “first published last year but currently getting some attention on Twitter” – that scientists should write their scientific papers as if they were telling a story, with a beginning, middle and end. The act of
Open Access
To quote from a paper published yesterday in PLOS Biology: Does the information shared in preprints typically withstand the scrutiny of peer review, or are conclusions likely to change in the version of record? We assessed preprints from bioRxiv and medRxiv that had been posted and subsequently published in a
glamour journals
Of all the scientific journals in the wild, there are a few I keep a closer eye on: they publish interesting results but more importantly they have been forward-thinking on matters of scientific publishing and they’ve also displayed a tendency to think out loud (through blog posts, say) and
Bharat Biotech
If you’re looking for a quantification (although you shouldn’t) of the extent to which science is being conducted by press releases in India at the moment, consider the following list of studies. The papers for none of them have been published – as preprints or ‘post-prints’ – even as the
COVID-19
I was slightly disappointed to read a report in the New York Times this morning. Entitled ‘Two Huge COVID-19 Studies Are Retracted After Scientists Sound Alarms’, it discussed the implications of two large studies of COVID-19 recently being retracted by two leading medical journals they were published in, the New
Ars Technica
There have been quite a few statements by various scientists on Twitter who, in pointing to some preprint paper’s untenable claims, point to the manuscript’s identity as a preprint paper as well. This is not fair, as I’ve argued many times before. A big part of the
bioRxiv
From an article entitled ‘The risks of swiftly spreading coronavirus research‘ published by Reuters: A Reuters analysis found that at least 153 studies – including epidemiological papers, genetic analyses and clinical reports – examining every aspect of the disease, now called COVID-19 – have been posted or published since the start of the
Bioinformatics
Twice this week, I’d had occasion to write about how science is an immutably human enterprise and therefore some of its loftier ideals are aspirational at best, and about how transparency is one of the chief USPs of preprint repositories and post-publication peer-review. As if on cue, I stumbled
